MedTrace Logo

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

NCT03862066 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2022-08-11

No results posted yet for this study

Summary

The purpose of this research study is collect tissue and blood samples from patients who are having surgery and use those samples in lab studies to see if there are any markers in blood and tissue that can help predict how cancer will react to different treatment. Participants in this study will have a blood sample and tissue samples collected for research. The blood and tissue collected will be tested in the laboratory. The tissue collected will be left over tissue from the standard of care surgery.

Conditions

  • Squamous Cell Carcinoma of the Head and Neck

Interventions

OTHER

Blood collection

5 milliliters (mL) of blood will be collected at the time of surgery

OTHER

Tissue collection

Left over tissue will be collected at the time of surgery

Sponsors & Collaborators

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • David Neskey, MD · Medical University of South Carolina

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2021-06-30
Completion
2021-11-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03862066 on ClinicalTrials.gov